198 related articles for article (PubMed ID: 2718657)
1. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
Man'kovskiĭ NB; Mints AIa; Karaban' IN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657
[TBL] [Abstract][Full Text] [Related]
2. [Use of sermion, Cavinton and trental in patients with cerebrovascular disorders].
Lebedeva NV; Khrapova EV
Sov Med; 1990; (1):60-3. PubMed ID: 2190329
[No Abstract] [Full Text] [Related]
3. [The dynamics of the cerebral circulation and of brain functional activity in patients with initial atherosclerotic encephalopathy under the influence of a single intravenous administration of sermion].
Mints AIa; Karaban' IN; Litvinenko AA
Farmakol Toksikol; 1991; 54(4):59-62. PubMed ID: 1786832
[TBL] [Abstract][Full Text] [Related]
4. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
Ishchenko MM; Shkrobot SI; Borak VT
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409
[TBL] [Abstract][Full Text] [Related]
5. [The effect of sermion on the main hemodynamic indices in patients with the initial manifestations of cerebral atherosclerosis].
Tokar' AV; Akhaladze NG; Ena LM; Rudaia ES; Severova NL
Vrach Delo; 1990 Feb; (2):27-30. PubMed ID: 2339544
[TBL] [Abstract][Full Text] [Related]
6. [The correction of microcirculatory disorders in patients with circulatory encephalopathy].
Vesel'skiĭ ISh; Sanik AV
Vrach Delo; 1991 Jul; (7):85-7. PubMed ID: 1771847
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
Burtsev EM; Shprakh VV; Savkov VS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):39-44. PubMed ID: 3364094
[TBL] [Abstract][Full Text] [Related]
8. [Sermion treatment of middle-aged and elderly patients with initial atherosclerotic encephalopathy].
Man'kovskiĭ NB; Mints AIa; Bachinskaia NIu; Kochubeĭ NV
Vrach Delo; 1989 Apr; (4):60-3. PubMed ID: 2756691
[TBL] [Abstract][Full Text] [Related]
9. [Current treatment of cerebrovascular disorder with vasoactive drugs].
Lebiediewa NW
Neurol Neurochir Pol; 1981; 15(4):417-21. PubMed ID: 6895779
[TBL] [Abstract][Full Text] [Related]
10. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
Samsó Dies JM; Villa Badó J; Villalobos J; Iriarte JL; Ordeix R
Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of (-)eburnamonine in comparison with nicergoline in patients suffering from chronic brain ischemia.
Marolda M; Fragassi N; Buscaino GA
Eur Neurol; 1978; 17 Suppl 1():159-66. PubMed ID: 381006
[TBL] [Abstract][Full Text] [Related]
12. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
Tamaki N; Kusunoki T; Matsumoto S
Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
[No Abstract] [Full Text] [Related]
13. [Treatment of circulatory encephalopathy with Cavinton].
Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
[No Abstract] [Full Text] [Related]
14. [About cavinton therapy of the patients with brain vascular diseases].
Nikitina VV; Pravdina AN; Zapatrina OV
Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
[No Abstract] [Full Text] [Related]
15. [10-year experience with using Cavinton in cerebrovascular disorders].
Burtsev EM; Savkov VS; Shprakh VV; Burtsev ME
Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):56-60. PubMed ID: 1319651
[TBL] [Abstract][Full Text] [Related]
16. Principles of pharmacologic correction of neurologic disorders in initial atherosclerotic encephalopathy.
Man'kovsky NB; Minz AY
Gerontology; 1988; 34(1-2):75-81. PubMed ID: 3384341
[TBL] [Abstract][Full Text] [Related]
17. [Serial angiographic evaluation of the effects of various vasoactive drugs on cerebral circulation in man].
Bernini FP; Smaltino F
Acta Neurol (Napoli); 1974 Mar; 29(2):170-84. PubMed ID: 4849693
[No Abstract] [Full Text] [Related]
18. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)].
Dauverchain J
Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956
[TBL] [Abstract][Full Text] [Related]
19. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
Burtsev EM; Shprakh VV; Savkov VS
Ross Med Zh; 1992; (2):41-3. PubMed ID: 1643337
[No Abstract] [Full Text] [Related]
20. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
Kugler JE; Meurer-Krüll BC
Arzneimittelforschung; 1985; 35(12):1865-70. PubMed ID: 3913425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
